Previous 10 | Next 10 |
BEDFORD, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (“HA”) technology platform , today provided an u...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Anika Therapeutics (NASDAQ: ANIK) delivered its fourth-quarter earnings report Thursday night , beat Wall Street's consensus estimates on both the top and bottom lines The medical technology company, which focuses on the $7 billion sports and regenerative medicine market, offers produ...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q4 2019 Earnings Call Feb 20, 2020 , 5:00 p.m. ET Operator Continue reading
Anika Therapeutics, Inc. (ANIK) Q4 2019 Earnings Conference Call February 20, 2020, 17:00 ET Company Participants Sylvia Cheung - CFO, Treasurer & Secretary Cheryl Blanchard - Interim CEO & Director James Loerop - EVP, Business Development & Strategic Planning Conf...
Anika Therapeutics (NASDAQ: ANIK ): Q4 Non-GAAP EPS of $0.43 beats by $0.01 ; GAAP EPS of $0.28 misses by $0.14 . More news on: Anika Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Total Revenue Increases 10% Year-over-Year for the Fourth Quarter Completes Acquisitions of Parcus Medical and Arthrosurface Company Expects Total Revenue Growth in the 40% to 44% Range for Full Year 2020 BEDFORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics,...
BEDFORD, Mass., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company’s Board of Directors since August 2018, has been named interim Chief Executive Officer, effective immediately, while the Bo...
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the close of the market on Thursday, February 20, 2019 and hold its investor conference call on the same day, Thursday, February 20, 2019, at...
BEDFORD, Mass., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform , today announced it h...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...